CASP3 and breast carcinoma: These LF-peptides inhibit the growth, adherence, and migration of breast cancer cells, promote cell death, induce cell cycle arrest, and lead to the overexpression of apoptosis-associated proteins, including caspase-3, -7, -8, and -9, thus hindering breast cancer progression.